Stone X Group Inc. Johnson & Johnson Transaction History

Stone X Group Inc.

$1.55 Billion
Q4 2024

A detailed history of Stone X Group Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Stone X Group Inc. holds 42,849 shares of JNJ stock, worth $6.69 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

42,849

Previous 30,490 40.53%

Holding current value

$6.69 Million

Previous $4.94 Million 25.42%

% of portfolio

0.4%

Previous 0.43%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$143.34 - $165.86 $1.77 Million - $2.05 Million	12,359 Added 40.53%	42,849 $6.2 Million
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $59,355 - $68,291	-408 Reduced 1.32%	30,490 $4.94 Million
Q2 2024 Aug 07, 2024	BUY	$144.38 - $157.78 $509,661 - $556,963	3,530 Added 12.9%	30,898 $4.52 Million
Q1 2024 May 01, 2024	BUY	$155.22 - $162.74 $614,205 - $643,962	3,957 Added 16.9%	27,368 $4.33 Million
Q4 2023 Feb 12, 2024	BUY	$145.6 - $158.88 $158,121 - $172,543	1,086 Added 4.86%	23,411 $3.67 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $28,190 - $31,580	-181 Reduced 0.8%	22,325 $3.48 Million
Q2 2023 Aug 11, 2023	BUY	$154.35 - $166.11 $115,453 - $124,250	748 Added 3.44%	22,506 $3.73 Million
Q1 2023 May 11, 2023	BUY	$151.05 - $180.26 $259,503 - $309,686	1,718 Added 8.57%	21,758 $3.37 Million
Q4 2022 Feb 10, 2023	BUY	$160.2 - $179.79 $230,047 - $258,178	1,436 Added 7.72%	20,040 $3.54 Million
Q3 2022 Nov 08, 2022	BUY	$161.33 - $179.52 $134,549 - $149,719	834 Added 4.69%	18,604 $3.04 Million
Q2 2022 Jul 27, 2022	BUY	$168.19 - $186.01 $2.99 Million - $3.31 Million	17,770 New	17,770 $3.15 Million
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $2.7 Million - $3.07 Million	-17,071 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$155.93 - $173.01 $338,212 - $375,258	2,169 Added 14.56%	17,071 $2.92 Million
Q3 2021 Oct 20, 2021	SELL	$161.5 - $179.47 $71,706 - $79,684	-444 Reduced 2.89%	14,902 $2.41 Million
Q2 2021 Aug 06, 2021	BUY	$159.48 - $171.07 $201,423 - $216,061	1,263 Added 8.97%	15,346 $2.53 Million
Q1 2021 Jun 23, 2021	BUY	$153.07 - $170.48 $44,084 - $49,098	288 Added 2.09%	14,083 $2.31 Million
Q4 2020 Feb 03, 2021	BUY	$137.11 - $157.38 $155,756 - $178,783	1,136 Added 8.97%	13,795 $2.17 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $202,568 - $221,976	1,443 Added 12.87%	12,659 $1.88 Million
Q2 2020 Aug 12, 2020	BUY	$128.81 - $155.51 $150,578 - $181,791	1,169 Added 11.64%	11,216 $1.58 Million
Q1 2020 Apr 30, 2020	BUY	$111.14 - $153.99 $90,356 - $125,193	813 Added 8.8%	10,047 $1.32 Million
Q4 2019 Jan 24, 2020	BUY	$127.5 - $146.44 $202,597 - $232,693	1,589 Added 20.78%	9,234 $1.35 Million
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $172,525 - $193,168	1,359 Added 21.62%	7,645 $989,000
Q2 2019 Jul 17, 2019	BUY	$131.15 - $144.24 $823,622 - $905,827	6,280 Added 104666.67%	6,286 $875,000
Q2 2019 Jul 12, 2019	SELL	$131.15 - $144.24 $752,932 - $828,081	-5,741 Reduced 99.9%	6 $0
Q1 2019 Apr 05, 2019	BUY	$125.72 - $139.79 $90,141 - $100,229	717 Added 14.25%	5,747 $0
Q4 2018 Jan 15, 2019	SELL	$122.84 - $147.84 $34,518 - $41,543	-281 Reduced 5.29%	5,030 $649,000
Q3 2018 Oct 03, 2018	BUY	$121.58 - $142.88 $75,987 - $89,300	625 Added 13.34%	5,311 $0
Q2 2018 Jul 23, 2018	BUY	$119.4 - $131.76 $179,816 - $198,430	1,506 Added 47.36%	4,686 $569,000
Q1 2018 Apr 19, 2018	BUY	$125.1 - $148.14 $34,402 - $40,738	275 Added 9.47%	3,180 $0
Q4 2017 Feb 09, 2018	BUY	$131.22 - $143.62 $29,655 - $32,458	226 Added 8.44%	2,905 $406,000
Q3 2017 Nov 13, 2017	SELL	$129.47 - $135.38 $3.91 Million - $4.09 Million	-30,230 Reduced 91.86%	2,679 $0
Q2 2017 Aug 31, 2017	BUY	N/A	32,909	32,909 $4.35 Million

Others Institutions Holding JNJ

# of Institutions

4,388

Shares Held

1.69B

Call Options Held

16.7M

Put Options Held

13.9M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $408B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.

Account